Clinical Trial Update: Riluzole to Treat Parkinson's Disease [Phase 2]

View source ↗

Summary

An update reports a Phase 2 trial evaluating riluzole for Parkinson's disease has completed. The provided snippet does not include trial outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Riluzole (riluzole)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED